The identification of rare genetic mutations in the amyloid precursor protein (APP), and the presenilins (PS1, PS2), as well as Trisomy 21 (Down syndrome, DS), that invariably lead to AD pathogenesis support the hypothesis that Aβ is an early, key player in the disease [3]. The gene discussed is APP; the disease is Down syndrome.